R Släter

1.5k citations

24 papers · 983 indexed · h-index 17

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Public Health, Environmental and Occupational Health top 5%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 17
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 9
Genetics 7
- Chronic Lymphocytic Leukemia Research 6

Co-authors: A. Veerman A van der Does-van den Berg K. Hählen C. Ellen van der Schoot BJ Bain Anthony V. Moorman G. John Swansbury LM Secker-Walker
Journals: Leukemia (9 papers)Blood (3 papers)British Journal of Haematology (1 paper)Bone Marrow Transplantation (1 paper)European Journal of Cancer (1 paper)
Partner nations: Netherlands Belgium United States

In The Last Decade

R Släter

24 papers receiving 952 citations

Peers

Countries citing papers authored by R Släter

Since Specialization

Citations

This map shows the geographic impact of R Släter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Släter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Släter more than expected).

Fields of papers citing papers by R Släter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Släter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Släter. The network helps show where R Släter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside R Släter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R Släter Line = papers co-authored together R Släter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features Leukemia ·Marian Stevens‐Kroef, Bruce Poppe, Toshio AKIYOSHI, Eva van den Berg, L Zhang, Ad Geurts van Kessel, R Släter, Guus Hamers, Lucienne Michaux, Frank Speleman, A Hagemeijer	2004	19
2	BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991–1996) Leukemia ·Jeffrey C. Chung, J.P.M. Bökkerink, Lucia Jančulová, A. Veerman, Lida Tzachani, ER van Wering, P.Amarjargal, J. Hermans, R Släter, Eva van den Berg, Małgorzata Migacz, A van der Does-van den Berg	2002	100
3	In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups Medical and Pediatric Oncology ·Раднаева Светлана Жамсоевна, R. Pieters, D. Hoelzer, R Släter, Monique L. den Boer, A. H. Loonen, Jochen Harbott, G. Janka‐Schaub, W.-D. Ludwig, G. J. Ossenkoppele, Elisabeth R. van Wering, A. Veerman	2002	18
4	MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7 Leukemia ·Dorota Maśniak, Erik A.C. Wiemer, b W. J. Aziz G. Z.Alwan, R Släter, MaryEllen Patterson, Yiwei Cai, Bronno van der Holt, M. Schoester, Rob Pieters, Pieter Sonneveld	2001	10
5	t(7;12)(q36;p13) and t(7;12)(q32;p13) – translocations involving ETV6 in children 18 months of age or younger with myeloid disorders Leukemia ·R Släter, B Ã–nen, Mr. Kannan Vijayan, D. Olde Weghuis, Eva van den Berg, Nazirov Sanjar, A van der Does-van den Berg, ER van Wering, K. Hählen, AJ Carroll, SC Raimondi, Ayu Chairina Laksmi	2001	44
6	In vitro drug resistance and prognostic impact of p16^INK4A/P15^INK4B deletions in childhood T‐cell acute lymphoblastic leukaemia British Journal of Haematology ·Раднаева Светлана Жамсоевна, R. Pieters, R Släter, A. H. Loonen, H. Berna Beverloo, Ellen van Drunen, Mats Heyman, Daria Moshinskaya, Marianne G. Rots, S.A. Jacques, W. A. Kamps, G. Janka‐Schaub, A. Veerman	2001	16
7	Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991 Leukemia ·WA Kamps, A. Veerman, ER van Wering, P.Amarjargal, R Släter, A van der Does-van den Berg	2000	50
8	Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests Bone Marrow Transplantation ·C. J. Van Assche, Moh Maftuhin, Bronno van der Holt, GJ Schuurhuis, Edo Vellenga, Vasily V. Atamonov, G.J. Ossenkoppele, Eva van den Berg, A Hagemeijer, R Släter, Zhenqiang Xu, Alison Cruse	2000	4
9	TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. PubMed ·Раднаева Светлана Жамсоевна, R. Pieters, A. H. Loonen, Isabelle Hubeek, Ellen van Drunen, H. Berna Beverloo, R Släter, Jochen Harbott, Jeanette Seyfarth, Elisabeth R. van Wering, K. Hählen, Kjeld Schmiegelow, Gritta Janka‐Schaub, A. Veerman	2000	104
10	T(7;12)(q36;p13) - A new translocation involving ETV6 associated with a poor prognosis in myeloid malignancies of very young children Data Archiving and Networked Services (DANS) ·R Släter, (unknown), Mr. Kannan Vijayan, (unknown), Eric N. van Roon, Magella Potvin, (unknown), A. Veerman, H. Berna Beverloo	1999	1
11	Human acute myeloid leukemia cells with internal tandem duplications in the Flt3 gene show reduced proliferative ability in stroma supported long-term cultures Leukemia ·Samantha Stenger, Annemiek Broyl, nbspShruti Pankajkumar Parekh, R Släter, RE Ploemacher	1999	19
12	Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set Leukemia ·Mirjam van der Burg, Ayu Chairina Laksmi, 李璇, K. Traxler, Ellen van Drunen, R Släter, Jacques J. M. van Dongen	1999	43
13	Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). PubMed ·Willem A. Kamps, J.P.M. Bökkerink, K. Hählen, J Hermans, H. Riehm, Helmut Gadner, Martin Schrappe, R Släter, Michael F. D'Amico, Lou A. Smets, G. A. M. de Vaan, Ron S. Weening, J.F. van der Weerden, Elisabeth R. van Wering, A van der Does-van den Berg	1999	83
14	Hematological malignancies with t(9;11)(p21–22;q23) – a laboratory and clinical study of 125 cases Leukemia ·G. John Swansbury, R Släter, BJ Bain, Anthony V. Moorman, LM Secker-Walker	1998	80
15	A constitutional balanced 1;17 neuroblastoma translocation European Journal of Cancer ·Terezinha Fatima de Souza, Peter van Sluis, Jan de Kraker, J.P.M. Bökkerink, Maarten Egeler, Geneviève Laureys, Voûte Pa, R Släter, A. Westerveld, Rogier Versteeg	1997	1
16	Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16) Leukemia ·Rachel H. Giles, David Rác, Meriem Berkani, Fred Petrij, J. Wessels, G.C. Beverstock, Hartmut Döhner, M Jotterand-Bellomo, Nurnanda Berninda, R Släter, Mestri Agustini Ni Nyoman, A. Hagemeijer, Ahmad Ali, M.H. Breuning	1997	55
17	A young child with acquired t(8;9)(p11;q34): additional proof that 8p11 is involved in mixed myeloid/T lymphoid malignancies. PubMed ·Henk van den Berg, Mr. Kannan Vijayan, C. Ellen van der Schoot, Rob Dee, Steven T. Pals, Tim Bouts, R Släter	1996	20
18	Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations. PubMed ·J. L. Huret, A. Brizard, R Släter, C Charrin, David J. Rogers, François Guilhot, K. Hählen, Mr. Kannan Vijayan, Youcef Dahmani, Sulvia Fernandes Borges Boccanera	1993	55
19	Characterization of a de novo duplication of 11p14→p13, using fluorescent in situ hybridization and Southern hybridization Cytogenetic and Genome Research ·Frank Speleman, M. Mannens, B. Redeker, M. Vercruyssen, Patrick Van Oostveldt, J. Leroy, R Släter	1991	10
20	Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood Blood ·Patricia Ferreira Nascimento, Bos Jl, R Släter, Miroslav. Parkan, J. Z. Zhang, LA Smets	1986	4

About R Släter

R Släter is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Neurology and Pediatrics, Perinatology and Child Health, having authored 24 papers that have together received 983 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Neuroblastoma Research and Treatments (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Hematology (606 citations), Public Health, Environmental and Occupational Health (543 citations), Pediatrics, Perinatology and Child Health (257 citations), Genetics (120 citations) and Molecular Biology (395 citations). R Släter has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include A. Veerman, A van der Does-van den Berg, K. Hählen, C. Ellen van der Schoot, BJ Bain, Anthony V. Moorman, G. John Swansbury, LM Secker-Walker, Ellen van Drunen and F. Lampert. Their work appears in journals such as Leukemia, Blood, British Journal of Haematology, Bone Marrow Transplantation and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact